Insulin resistance in chronic kidney disease: a systematic review

B Spoto, A Pisano, C Zoccali - American Journal of …, 2016 - journals.physiology.org
Insulin resistance (IR) is an early metabolic alteration in chronic kidney disease (CKD)
patients, being apparent when the glomerular filtration rate is still within the normal range …

Insulin resistance in patients with chronic kidney disease

MT Liao, CC Sung, KC Hung, CC Wu… - BioMed research …, 2012 - Wiley Online Library
Metabolic syndrome and its components are associated with chronic kidney disease (CKD)
development. Insulin resistance (IR) plays a central role in the metabolic syndrome and is …

Insulin resistance in patients with chronic kidney disease

S Kobayashi, K Maesato, H Moriya, T Ohtake… - American Journal of …, 2005 - Elsevier
Background: It has been reported that insulin resistance appears at an earlier stage of
chronic kidney disease (CKD). However, few data are available concerning what factors of …

Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease

C Lo, T Toyama, Y Wang, J Lin… - Cochrane database …, 2018 - cochranelibrary.com
Background Diabetes is the commonest cause of chronic kidney disease (CKD). Both
conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes …

Exploring metabolic dysfunction in chronic kidney disease

AD Slee - Nutrition & metabolism, 2012 - Springer
Impaired kidney function and chronic kidney disease (CKD) leading to kidney failure and
end-stage renal disease (ESRD) is a serious medical condition associated with increased …

Insulin therapy in renal disease

P Iglesias, JJ Díez - Diabetes, Obesity and Metabolism, 2008 - Wiley Online Library
Diabetes mellitus (DM) is the main cause of end‐stage renal disease (ESRD). Conversely,
chronic renal failure (CRF) is also associated with diverse alterations in carbohydrate and …

Relationship between chronic kidney disease and metabolic syndrome: current perspectives

K Nashar, BM Egan - … Syndrome and Obesity: Targets and Therapy, 2014 - Taylor & Francis
Both metabolic syndrome (MetS) and chronic kidney disease (CKD) are increasing in
incidence and lead to significant cardiovascular morbidity and mortality. The relationship …

Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function

JW Huang, CJ Yen, HW Chiang, KY Hung… - American journal of …, 2004 - Elsevier
Background: Adiponectin, a cytokine with anti-inflammatory properties that is secreted from
adipose tissue, is associated with insulin resistance. Adiponectin has been shown to be a …

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized …

CK Boughton, A Tripyla, S Hartnell, A Daly, D Herzig… - Nature medicine, 2021 - nature.com
We evaluated the safety and efficacy of fully closed-loop insulin therapy compared with
standard insulin therapy in adults with type 2 diabetes requiring dialysis. In an open-label …

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

M Oshima, M Jun, KL Chin, CM Hawley… - Cochrane Database …, 2020 - cochranelibrary.com
Background Kidney transplantation is the preferred management for patients with end‐stage
kidney disease (ESKD). However, it is often complicated by worsening or new‐onset …